Third Rock spinout Faze Medicines appears to be shutting down


Faze Medicines, a neuroscience-focused startup that spun out of Third Rock Ventures in late 2020, is winding down.

Previous AdventHealth gives $1.7M to Tampa Bay college to boost nursing program
Next WakeMed, Duke Health argue no harm done in Facebook-patient data case